Banydeen, R.; Eggleston, R.; Deney, A.; Monfort, A.; Ryu, J.H.; Vergaro, G.; Castiglione, V.; Lairez, O.; Emdin, M.; Inamo, J.;
et al. Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry. J. Clin. Med. 2023, 12, 3684.
https://doi.org/10.3390/jcm12113684
AMA Style
Banydeen R, Eggleston R, Deney A, Monfort A, Ryu JH, Vergaro G, Castiglione V, Lairez O, Emdin M, Inamo J,
et al. Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry. Journal of Clinical Medicine. 2023; 12(11):3684.
https://doi.org/10.3390/jcm12113684
Chicago/Turabian Style
Banydeen, Rishika, Reid Eggleston, Antoine Deney, Astrid Monfort, Jay H. Ryu, Giuseppe Vergaro, Vincenzo Castiglione, Olivier Lairez, Michele Emdin, Jocelyn Inamo,
and et al. 2023. "Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry" Journal of Clinical Medicine 12, no. 11: 3684.
https://doi.org/10.3390/jcm12113684
APA Style
Banydeen, R., Eggleston, R., Deney, A., Monfort, A., Ryu, J. H., Vergaro, G., Castiglione, V., Lairez, O., Emdin, M., Inamo, J., Baqir, M., & Neviere, R.
(2023). Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry. Journal of Clinical Medicine, 12(11), 3684.
https://doi.org/10.3390/jcm12113684
